Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials

<p>Abstract</p> <p>Background</p> <p>In this meta-analysis we aimed to determine the effectiveness and safety of hyperthermic intraperitoneal chemotherapy (HIPC) for patients with advanced gastric cancer who underwent gastrectomy.</p> <p>Methods</p> &l...

Full description

Bibliographic Details
Main Authors:	Sun Jingxu, Song Yongxi, Wang Zhenning, Gao Peng, Chen Xiaowan, Xu Yingying, Liang Jiwang, Xu Huimian
Format:	Article
Language:	English
Published:	BMC 2012-11-01
Series:	BMC Cancer
Subjects:	Hyperthermic intraperitoneal chemotherapy Gastric cancer Peritoneal recurrence Meta-analysis
Online Access:	http://www.biomedcentral.com/1471-2407/12/526

Similar Items

Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery
by: Hsin-Hsien Yu, et al.
Published: (2023-06-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer with Peritoneal Metastasis—Indian Experience
by: Somashekhar S.P, et al.
Published: (2022-04-01)

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Carcinomatosis: Additional Information Helps to Optimize Patient Selection before Surgery
by: Hao-Chien Hung, et al.
Published: (2023-03-01)

Efficacy with prognostic value of postoperative prophylactic hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer
by: SUN Qi, HUANG Wenbo, HE Bingliang, LIU Chang, XU Yuhang, ZHAO Wei
Published: (2023-07-01)

Lobaplatin in Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: Safety and Efficacy Profiles
by: Zhong Y, et al.
Published: (2020-06-01)

A case report of hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) for malignant peritoneal mesothelioma
by: Hanjian Liu, et al.
Published: (2023-12-01)

Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
by: Özgül Düzgün, et al.
Published: (2019-09-01)

Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study
by: Lucheng Zhu, et al.
Published: (2020-08-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique
by: Talgat Uskenbayev, et al.
Published: (2019-06-01)

Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
by: Jieun Ko, et al.
Published: (2021-09-01)

Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model
by: Manoğlu Berke, et al.
Published: (2023-05-01)

Rhabdomyolysis after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report
by: Rob Bielen, et al.
Published: (2013-01-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
by: Adriana C. Gamboa, et al.
Published: (2019-10-01)

A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer
by: Lili Liu, et al.
Published: (2022-12-01)

Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
by: Yarema Roman
Published: (2017-12-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis
by: Seung Jae Roh, et al.
Published: (2020-02-01)

Intraperitoneal perfusion chemotherapy and whole abdominal hyperthermia using external radiofrequency following radical D2 resection for treatment of advanced gastric cancer
by: Lucheng Zhu, et al.
Published: (2019-01-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
by: W. J. Koemans, et al.
Published: (2019-05-01)

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
by: Daan R. Löke, et al.
Published: (2020-11-01)

The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy
by: Iason Psilopatis, et al.
Published: (2023-08-01)

Is There a Role for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis Due to Uterine Cancer?
by: Özgül Düzgün, et al.
Published: (2022-10-01)

The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Maher Al Khaldi, et al.
Published: (2022-11-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials
by: Kevin M. Turner, et al.
Published: (2022-06-01)

The impact of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery on clinical outcomes and quality of life of patients with peritoneal carcinomatosis
by: Oleksandr Vadymovych Bondar, et al.
Published: (2021-12-01)

Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Maria Consuelo Pintado, et al.
Published: (2023-06-01)

The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
by: Hao-Chien Hung, et al.
Published: (2021-12-01)

The Registry of Hyperthermic Intraperitoneal Chemotherapy – A Mandatory Step in the Development of this Therapeutic Approach in Romania
by: Corneliu LUNGOCI, et al.
Published: (2015-03-01)

Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: The experience of a tertiary Asian center
by: Melissa Ching Ching Teo, et al.
Published: (2015-04-01)

Intraperitoneal Paclitaxel Is Useful as Adjuvant Chemotherapy for Advanced Gastric Cancer with Serosal Exposure
by: Joji Kitayama, et al.
Published: (2014-01-01)

Side-effects of hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal cancers
by: Jiyun Hu, et al.
Published: (2023-04-01)

Initial Experience of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Baltic Country Center
by: Rokas Račkauskas, et al.
Published: (2022-09-01)

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study
by: Leonardo Solaini, et al.
Published: (2019-03-01)

Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Patients at High Risk of Developing Gallbladder Cancer Peritoneal Metastases: Case Report and Rationale for a Prospective Clinical Trial
by: Alexander E. Crum, et al.
Published: (2024-01-01)

Postoperative oxaliplatin-based hyperthermic intraperitoneal chemotherapy: an effective and safe palliative treatment option for colorectal cancer with peritoneal metastasis
by: Tuanhe Sun, et al.
Published: (2021-07-01)

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: JAIRO SEBASTIÁN ASTUDILLO VALLEJO, et al.
Published: (2023-04-01)

Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Chao-Yu Chen, et al.
Published: (2020-01-01)

Drain site enterocutaneous fistula after hyperthermic intraperitoneal chemotherapy
by: Navin Kumar, et al.
Published: (2021-01-01)

Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
by: Falla-Zuniga Luis Felipe, et al.
Published: (2023-12-01)

Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles
by: Jing Zhang, et al.
Published: (2023-03-01)

Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting outcomes for peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: Wei-Liang Loh, et al.
Published: (2017-01-01)